Akeso, Inc.: Akeso Announces First ADC Drug Clinical Trial, Marking a New Era for "IO 2.0 + ADC" Strategy
Akeso, Inc. (9926.HK) announced the first patient has been enrolled in the Phase I clinical trial of AK138 D1 for the treatment ...
Akeso Announces First ADC Drug Clinical Trial, Marking A New Era For IO 2.0 + ADC Strategy
HONG KONG, Feb. 27, 2025 /PRNewswire/ -- Akeso, Inc. (9926) announced the first patient has been enrolled in the Phase I clinical trial of AK138 D1 for the treatment of advanced malignancies in ...
Crying disease in Congo: All you need to know about the illnesses that have sickened over 400 people
Unidentified illnesses in northwestern Congo have killed more than 50 people over the past five weeks, nearly half of them ...
Blinkit starts 10-minute delivery for MacBook, iPad, Watch and other Apple accessories in these cities
Blinkit has introduced 10-minute delivery for Apple products, including MacBook Air, iPad, AirPods, Apple Watch, and ...